One of the greatest challenges of modern-day science is to address the rise of multidrug-resistant diseases and the need for new functional antibiotics. In a study published in PNAS (Proceedings of the National Academy of Sciences), researchers at Stockholm University describe the mode of action of a potential anti-tuberculosis (anti-TB) compound, lansoprazole sulphide.